Intralesional Injection Of Methotrexate Versus Triamcinolone Acetonid In Treatment Of Localized Psoriasis

Not Applicable

• Conditions: Localized Psoriasis
• Interventions: Drug: Intralesional Injection of Methotrexate; Drug: Triamcinolone Acetonid

• Registration Number: NCT05408208
• Lead Sponsor: Sohag University

Brief Summary

The aim of the present study is to evaluate the efficacy of intralesional injection of methotrexate in comparison with Intralesional Injection of Triamcinolone Acetonid in localized psoriasis (body surface area \< 10%) .

Detailed Description

study enrolling 30 patients of localized psoriasis. 15 patients received intralesional methotrexate :

* Taking aseptic condition ,One psoriatic plaque will treated with Intralesional injection of methotrexate (25mg /ml) at dosage of 0.1 ml /cm2.

* Another plaque will treated with intralesional ingection of distilled water as controlled plaque.

* patient will receive oral folic acid 5mg tablet every day except the day of injection.

Other 15 patients received intralesional trimethinolone acetonide:

* Taking aseptic condition , One plaque will treated with Intralesional injection of trimethinolone acetonide (10mg/ml) at dosage of 0.1 ml/ cm2 .

* another plaque will treated with Intralesional injection of distilled water as controed plaque.

* Patients will take 6 sessions every 2 weeks for 3 months and will followed up at 2 month and 3 months after treatment .

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study Start: 2022-05-21
• Study First Submitted: 2022-05-22
• Status Verified: 2022-06
• Study First Submitted QC: 2022-06-01
• Last Update Submitted: 2022-06-01
• Study First Posted: 2022-06-07
• Last Update Posted: 2022-06-07
• Primary Completion: 2022-11-21
• Study Completion: 2023-05-21

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

• patients with localized Psoriasis (body surface area<10%)

Read More

Exclusion Criteria

• Patient refusal. Generalized psoriasis. Pregnancy. Lactation. Immunocompromised patients . Patients with history of hypersensitivity to methotrexate. Patients with other inflammatory skin disorders. Patients with chronic hepatic, renal , pulmonary ,or haematological disorders. patients on treatment for psoriasis .

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Methotrexate	Intralesional Injection of Methotrexate	Intralesional injection of methotrexate
Methotrexate	Triamcinolone Acetonid	Intralesional injection of methotrexate
Triamcinolone Acetonid	Intralesional Injection of Methotrexate	Intralesional injection of trimethinolone acetonide
Triamcinolone Acetonid	Triamcinolone Acetonid	Intralesional injection of trimethinolone acetonide

Primary Outcome Measures

Name	Time	Method
Efficacy Of Intralesional Injection Of Methotrexate Versus Triamcinolone Acetonid In Treatment Of Localized Psoriasis	3 months after treatment	clinical and dermoscopic changes according to psoriasis area severity index

Trial Locations

Locations (1)

Sohag University; 🇪🇬 Sohag, Egypt